Dr. Epstein Presents - Biosimilars in the Rheumatic Diseases - Part 2: Scientific Considerations and Concerns for the Clinician

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Dr. Epstein Presents - Biosimilars in the Rheumatic Diseases - Part 2: Scientific Considerations and Concerns for the Clinician

By West Virginia State Rheumatology Society FEATURING Alan Epstein

4 views

August 9, 2023

0 Comments

Identifying Eosinophilic Granulomatosis With Polyangiitis and Hypere…

Feat. M. O'Connor

Moderate-to-Severe Plaque Psoriasis: Patient Case Study and Clinical…

Feat. M. Jackson

Contemporary Topics in Vasculitis

Fri, May 3, 2024

UCSD

UC SAN DIEGO LUPUS CENTER OF EXCELLENCE: 2024 PATIENT SYMPOSIUM ON L…

Sat, May 4, 2024

USSONAR

2024 USSONAR Multi-Track Ultrasound in Rheumatology Conference

Fri, May 17, 2024

West Virginia State Rheumatology Society

West Virginia Immunology Summit

Fri, Jun 7, 2024

11:15

Cleveland Clinic Rheumatology and Immunology Series

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Feat. A. Brown

07:01

John Tayek

Osteoporosis & Vitamin D: Does Vitamin D Reduce Falls/Fractures …

18:44

ACR Convergence 2021 Coverage

Calcium and Vitamin D Supplementation to Prevent and Manage Osteopor…

Feat. N. Lane

15:45

Daniel Arkfeld

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Cleveland Clinic Rheumatology and Immunology Series

Cleveland Clinic Rheumatology and Immunology Pearls Now Presented Ex…

Feat. L. Calabrese, A. Brown

52:53

University of Colorado Department of Medicine

Interstitial Lung Disease in Rheumatic Diseases

Feat. M. Griffith

17:39

Saakshi Khattri

Dermatologic Manifestations in Rheumatic Diseases

21:41

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

Feat. S. Metyas

14:09

Keck School of Medicine of USC

Vitamin D Deficiency

Feat. V. Gevorgyan

43:45

University of Colorado Department of Medicine

Advances in Rheumatoid Arthritis Associated Interstitial Lung Disease

Feat. J. Lee

11:54

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Embedding Treat to Target Principle…

Feat. S. Dowell

23:59

RheumNow

Methotrexate Use: 50 Year Perspective

Feat. J. Kremer

25:25

Keck School of Medicine of USC

Update on the New ANA Classification System

Feat. E. Taylor-Albert

34:08

Keck School of Medicine of USC

Medical Marijuana in Rheumatology: Fact or Fiction?

Feat. A. Wells

08:47

USSONAR

USSONAR Rheumatology Ultrasound Case Series: Rheumatoid Arthritis an…

Feat. J. Yinh

22:04

Grant Garcia

Updates in Treatment of Osteoarthritis

07:14

RheumNow

Hard Decisions: HSV and RSV Update for Rheumatology

Feat. K. Winthrop

40:59

UCSF School of Medicine

Lessons in Autoimmunity from the World of Primary Immunodeficiency D…

Feat. T. Torgerson

14:36

Laura Coates

Login

Login

Join VuMedi

Dr. Epstein Presents - Biosimilars in the Rheumatic Diseases - Part 2: Scientific Considerations and Concerns for the Clinician

Related Content